CompletedPhase 1NCT00304018
Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer
Studying Acute erythroid leukemia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of California, San Francisco
- Principal Investigator
- Thomas G. Martin, MDUniversity of California, San Francisco
- Intervention
- anti-thymocyte globulin(biological)
- Enrollment
- 5 enrolled
- Eligibility
- 18-55 years · All sexes
- Timeline
- 2002 – 2009
Study locations (1)
- UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, United States
Collaborators
National Cancer Institute (NCI)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00304018 on ClinicalTrials.govOther trials for Acute erythroid leukemia
Additional recruiting or active studies for the same condition.